MariMed Stock

MariMed ROCE

The Return on Capital Employed (ROCE) of MariMed (MRMD) as of Aug 14, 2026 is -1.50 %. In the previous year, Return on Capital Employed (ROCE) was 5.38 % — a change of -127.93% (lower).

ROCE

-1.50 %

YoY

-127.93%

Last updated:

In 2026, MariMed's return on capital employed (ROCE) was -1.50 %, a -127.93% increase from the 5.38 % ROCE in the previous year.

Access this data via the Eulerpool API
Get Free API Key

MariMed Stock analysis

What does MariMed do? Marimed Inc is a leading company in the development of medical cannabis and hemp products. The company was founded in 2011 and has since made a name for itself through its innovative products and its focus on research and development of plant-based products. Marimed Inc's business model is based on the research, development, and marketing of cannabis products. The company focuses on the development of medical cannabis products as well as the trade in hemp products. The product range includes oils, tinctures, capsules, vaporizers, and other electronic devices. The various divisions of Marimed Inc include research and development, marketing, distribution, and licensing of medical cannabis. As a fully integrated company, Marimed Inc has its own cultivation, processing, and shipping infrastructure to ensure smooth delivery of high-quality cannabis products. Another focus of the company is research, which focuses on the development of new cannabinoid compounds for the treatment of diseases such as epilepsy, inflammation, and arthritis. Thanks to this research, new products are constantly being developed to guarantee customers high effectiveness and quality. An important factor for the success of Marimed Inc is its responsibility towards the environment and society. The company places great value on working sustainably and environmentally friendly, as well as convincing society of the benefits of medical cannabis products. Among the products offered by Marimed Inc are the products of the Betty's Eddies brand. These products are specifically designed for patients suffering from ailments such as anxiety, insomnia, and pain. Betty's Eddies guarantees high effectiveness and a pleasant taste with its products. Another product offered by Marimed Inc is the MariCann Vaporizer System. The vaporizer is a fast and easy way to consume medical cannabis without burdening the body. The device is suitable for both medical cannabis patients and recreational users. Marimed Inc is a company that is always looking for new solutions and innovations to offer customers the best possible quality. The company is heavily involved in research and development to improve the quality of its products and promote the positive effects of medical cannabis on society. Marimed Inc is a company that can be trusted when it comes to medical cannabis and other hemp products. MariMed is one of the most popular companies on Eulerpool.

ROCE Details

Unraveling MariMed's Return on Capital Employed (ROCE)

MariMed's Return on Capital Employed (ROCE) is a financial metric that measures the company's profitability and efficiency with respect to the capital employed. It is calculated by dividing earnings before interest and tax (EBIT) by the employed capital. A higher ROCE indicates that the company is effectively utilizing its capital to generate profits.

Year-to-Year Comparison

Analyzing MariMed's ROCE annually provides valuable insights into its efficiency in using its capital to generate profits. An increasing ROCE indicates improved profitability and operational efficiency, whereas a decrease might signal potential issues in capital utilization or business operations.

Impact on Investments

MariMed's ROCE is a critical factor for investors and analysts for evaluating the company’s efficiency and profitability. A higher ROCE can make the company an attractive investment, as it often signifies that the firm is generating adequate profits from its employed capital.

Interpreting ROCE Fluctuations

Changes in MariMed’s ROCE are attributed to variations in EBIT or the capital employed. These fluctuations offer insights into the company’s operational efficiency, financial performance, and strategic financial management, assisting investors in making informed investment decisions.

Frequently Asked Questions about MariMed stock

Return on Capital Employed (ROCE) of MariMed is -1.50 % in 2026.

Return on Capital Employed (ROCE) of MariMed changed from 5.38 % to -1.50 %, representing a -127.93% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of Return on Capital Employed (ROCE) MariMed since 2006 – with annual values, charts, and detailed analysis.

ROCE is a profitability measure and stands for Return on Capital Employed or the return on invested capital. The measure shows the ratio of operating profit to the interest-bearing capital employed. The higher the return on capital employed, the more profitable a company operates and the higher the important free cash flow. The free cash flow refers to the portion of profits that is not needed for expanding the company at the end of a period, but is available to shareholders.

A 'good' varies by industry and company stage. On Eulerpool, you can compare Return on Capital Employed (ROCE)'s MariMed with sector peers and the industry average to assess whether it is attractive.

To evaluate Return on Capital Employed (ROCE)'s, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for Return on Capital Employed (ROCE).

Access this data via the Eulerpool API
Get Free API Key

Profitability — MariMed

ROEROAROCEROICAsset TurnoverInventory TurnoverReceivables TurnoverDays Sales OutstandingDays Inventory OutstandingDays Payable OutstandingCash Conversion CycleCROICGross Profit/AssetsFixed Asset TurnoverEquity TurnoverWorking Capital TurnoverPayables TurnoverCapital IntensityReceivables/RevenueInventory/RevenueEBIT/Assets

All Key Metrics — MariMed